Status:
WITHDRAWN
A Retrospective Review - Anti-HLA Antibodies
Lead Sponsor:
Emory University
Conditions:
Congenital Disorders
Eligibility:
All Genders
Up to 18 years
Brief Summary
Transplant rejection following organ transplant occurs because the recipient's immune system attacks the transplanted organ. The recipients immune system recognizes the transplanted organ as foreign t...
Detailed Description
It is generally thought that immunologic mismatching in solid organ transplant will lead to increased rates of graft failure due to acute rejection in the short term and chronic rejection, or coronary...
Eligibility Criteria
Inclusion
- heart transplants at Childrens Healthcare of Atlanta, Egleston Hospital
- transplants between July 1, 1988 through and including January 31, 2007
- complete HLA data
- survived more than 30 days after transplant
Exclusion
- subjects undergoing retransplant
Key Trial Info
Start Date :
July 1 1988
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00460824
Start Date
July 1 1988
Last Update
December 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322